跳至主要内容
临床试验/TCTR20230908002
TCTR20230908002Enrolling By Invitation2 期

Comparing adrenal venous sampling outcomes in primary aldosteronism with concurrent versus discontinued use of mineralocorticoid receptor antagonist: a randomized-controlled trial.

Faculty of Medicine, Chiang Mai University0 个研究点目标入组 50 人开始时间: 2023年9月8日最近更新:
适应症

试验速览

阶段
2 期
状态
Enrolling By Invitation
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 Years 至 70 Years(—)
性别
All

入选标准

  • 1. Patients with a confirmed diagnosis of PA according to the criteria of the Endocrine Society Clinical Practice guideline 2016
  • 2. Be ready and have indications for doing AVS
  • 3. AVS results with a selectivity index confirm that the catheter is in the adrenal vein and AVS results confirm that it is in unilateral form.
  • 4. 20-70 years old

排除标准

  • 1. Patients who do not consent to AVS
  • 2. Patients who can skip unilateral adrenalectomy without AVS
  • 2.1 Patients < 35 years old with unilateral adenoma on CT or MRI with obvious PA characteristics (PAC > 30 ng/dL and spontaneously low potassium).
  • 2.2 Patients suspected of adrenal cancer (adrenocortical carcinoma)
  • 3. Patients diagnosed with familial hyperaldosteronism type I and III.

研究者

相似试验

Comparing adrenal venous sampling outcomes in... | 临床试验